Chiasma Inc (CHMA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

140 KENDRICK STREET NEEDHAM, MA 02494

Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. In June 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA, the first and only oral somatostatin analog approved by the FDA, is available for commercial sale. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma.

Data as of 2021-08-22 12:04:00 -0400
Market Cap0 Shares Outstanding57.894 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date Price to Cash FLow (P/CF) -8.963
Data provided by IEX Cloud
View SEC Filings from CHMA instead.

View recent insider trading info

Funds Holding CHMA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CHMA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THERO JOHN F

  • Director
0 2021-08-05 1

STACK DAVID M

  • Director
0 2021-08-05 2

SCARLETT JOHN A

  • Director
0 2021-08-05 1

STONEPINE CAPITAL, L.P.

  • 10% Owner
0 2021-08-05 1

FOLEY TODD

  • Director
0 2021-08-05 1

MINICK SCOTT

  • Director
0 2021-08-05 1

MAMLUK RONI

  • Director
0 2021-08-05 2

GEESAMAN BARD

  • Director
0 2021-08-05 2

VARADAN ANAND EVP, CHIEF COMMERICAL OFFICER

  • Officer
0 2021-08-05 2

ENAMAIT DREW VP, FIN & ADMIN, PAO

  • Officer
0 2021-08-05 2

LUDLAM WILLIAM SEE REMARKS

  • Officer
0 2021-08-05 2

KANNAN RAJ CEO AND PRESIDENT

  • Officer
  • Director
0 2021-08-05 3

GIGUERE LEE GENERAL COUNSEL

  • Officer
0 2021-08-05 2

DOYLE JOHN BRENDAN CHIEF FINANCIAL OFFICER

  • Officer
0 2021-08-05 3

STONEPINE CAPITAL MANAGEMENT, LLC

  • 10% Owner
6,770,000 2021-05-06 1

FITZPATRICK MARK J. PRESIDENT

  • Officer
19,612 2020-12-04 1

GADICKE ANSBERT

  • Director
0 2016-06-09 0

TOBIN JAMES R

  • Director
0 2016-06-09 0

LEUCHTENBERGER MARK CEO, PRESIDENT

  • Officer
  • Director
0 2016-02-10 0

MCCARTHY TARA GENERAL COUNSEL AND SECRETARY

  • Officer
0 2016-02-01 0

MPM BIOVENTURES IV QP LP

EVNIN LUKE

SCOPA JAMES PAUL

KAILIAN VAUGHN M

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIO IV NVS STRATEGIC FUND LP

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

  • 10% Owner
5,681,544 2015-07-21 0

7-MED HEALTH VENTURES LP

WERTHEIMER RUTH

  • 10% Owner
1,709,932 2015-07-21 0

MILES VINCENT J

  • Director
  • 10% Owner
0 2015-07-15 0

ORLEV CHAIME SEE REMARKS

  • Officer
0 2015-07-15 0

ABINGWORTH LLP

  • 10% Owner
2,600,741 2015-07-15 0

GLOBEWAYS HOLDINGS LTD

  • 10% Owner
0 2015-07-15 0

GLOBEWAYS HOLDINGS LTD

LJ SKYE TRUSTEES LTD.

F2 CAPITAL I 2014 LTD

  • 10% Owner
0 2015-07-15 0

DROR BRANDWEIN

  • Director
0 2015-07-15 0

7-MED HEALTH VENTURES LP

  • 10% Owner
273,762 2015-07-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CHIASMA INC CHMA 2021-08-05 22:15:04 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 21:45:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 21:15:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 20:45:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 20:15:04 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 19:45:04 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 19:15:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 18:45:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 18:15:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 17:45:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 17:15:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 16:45:02 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 16:15:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 15:45:03 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 15:15:02 UTC -1.1965 1.2765 1700000
CHIASMA INC CHMA 2021-08-05 14:45:02 UTC -1.2344 1.3144 1700000
CHIASMA INC CHMA 2021-08-05 14:15:04 UTC -1.2344 1.3144 1700000
CHIASMA INC CHMA 2021-08-05 13:45:04 UTC -1.2344 1.3144 1700000
CHIASMA INC CHMA 2021-08-05 13:15:03 UTC -1.2344 1.3144 1700000
CHIASMA INC CHMA 2021-08-05 12:45:03 UTC -1.2344 1.3144 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CHMA -2200.0 shares, $-10406.0 2021-06-30 N-PORT

Elevate your investments